In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 3: Interventional cardiology, Coronary
Session

Event : Acute Cardiovascular Care 2016

Topic : Other

  • Session type : Poster Session
  • Date : 16 October 2016
  • Time : 10:30 - 14:30

7 presentations in this session

Acute kidney injury after percutaneus coronary intervention to unprotected left main coronary artery in patients with acute coronary syndrome

Event : Acute Cardiovascular Care 2016

  • Session : Interventional cardiology, Coronary
  • Speaker : RJ Cobas Paz (Pontevedra,ES)

Clinical results at long-term follow-up of percutaneous coronary intervention in left main coronary artery disease

Event : Acute Cardiovascular Care 2016

  • Session : Interventional cardiology, Coronary
  • Speaker : J Piqueras Flores (Ciudad Real,ES)

Impact of second-generation coated stents use in long-term prognosis of non-surgical unprotected left main coronary artery (LMCA) disease.

Event : Acute Cardiovascular Care 2016

  • Session : Interventional cardiology, Coronary
  • Speaker : C Ramirez Guijarro (Albacete,ES)

Impella CP in the high-risk percutaneous coronary intervention: Initial experience of a single center

Event : Acute Cardiovascular Care 2016

  • Session : Interventional cardiology, Coronary
  • Speaker : DC Mbala (Vila Nova De Gaia,PT)

Restenosis in the first year following bifurcation lesions angioplasty

Event : Acute Cardiovascular Care 2016

  • Session : Interventional cardiology, Coronary
  • Speaker : B Rekik (Sfax,TN)

STEMI due to unprotected left main coronary artery culprit lesion: What do we know?

Event : Acute Cardiovascular Care 2016

  • Session : Interventional cardiology, Coronary

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are